Dabrafenib (Tafinlar®) is used to treat patients with:
• Melanoma that has a genetic mutation called BRAF V600E or V600K and may be used in combination with trametinib.
• Non-small cell lung cancer that has a genetic mutation called BRAF V600E and is used in combination with trametinib.
•Anaplastic thyroid cancer that has a genetic mutation called BRAF V600E and may be used in combination with trametinib
Our Medication Sheet
This sheet is available to download as an Adobe PDF.